With annual CPhI events being a big part of the pharma calendar, the industry will no doubt be relieved to see the announcement of rescheduled dates, rather than cancellations.

CPhI has worked quickly to secure new dates for a handful of its 2020 events, and so far has confirmed new exhibition dates for CPhI Japan, CPhI South East Asia and CPhI North America;  it’s further announced that it is proactively looking into more digital content options for its audience which is likely to be much appreciated in these tough times.

Read the full announcement here and be sure to also check out the QUINTA-ANALYTICA blog post which covers not only CPhI, but also other pharma events which are cancelled or rescheduled in the coming months.

Additional News

  • 15 July 2026

    Quinta-Analytica Awarded the EcoVadis Gold Medal

    Quinta-Analytica has been awarded the EcoVadis Gold Medal after achieving an overall sustainability score of 84 out of 100. The result represents a substantial increase from 68 points in the previous assessment and places the company in the 97th percentile globally.

  • 16 April 2026

    Expanding Beyond FDA & EMA: Strengthening Our Global Regulatory Footprint with GCC

    Quinta-Analytica has successfully completed a full on-site GCP inspection within the GCC framework, further strengthening its international regulatory footprint and clinical research credibility.

  • 25 March 2026

    ADC Webinar: DAR, Bioanalysis and Intact MS in Next-Generation ADC Development

    On behalf of Conscio Group, registration is now open for our free expert-led webinar on DAR characterization, bioanalytical strategy and mass spectrometry insight in ADC development.